本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fate Therapeutics Inc

1.04
-0.0400-3.70%
盘后1.040.00000.00%18:22 EDT
成交量:86.95万
成交额:90.70万
市值:1.19亿
市盈率:-0.70
高:1.08
开:1.08
低:1.02
收:1.08
数据加载中...
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/17

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/06/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

重要事件披露

Form 8-K - Current report
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/05

重要事件披露

Form 8-K - Current report
2025/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/06

重要事件披露

Form 8-K - Current report
2024/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/29

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/25

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]